Solid Biosciences (SLDB) Operating Income (2017 - 2026)
Quarterly results put Operating Income at -$57.3 million for Q1 2026, down 43.08% from a year ago — trailing twelve months through Mar 2026 was -$196.5 million (down 37.46% YoY), and the annual figure for FY2025 was -$179.2 million, down 38.14%.
Solid Biosciences has reported Operating Income over the past 10 years, most recently at -$57.3 million for Q1 2026.
- Operating Income reached -$57.3 million in Q1 2026 per SLDB's latest filing, down from -$49.4 million in the prior quarter.
- Across five years, Operating Income topped out at -$21.1 million in Q3 2022 and bottomed at -$57.3 million in Q1 2026.
- Median Operating Income over the past 5 years was -$32.0 million (2023), compared with a mean of -$33.9 million.
- The largest annual shift saw Operating Income tumbled 85.32% in 2022 before it skyrocketed 35.59% in 2023.
- Over 5 years, Operating Income stood at -$34.6 million in 2022, then surged by 35.59% to -$22.3 million in 2023, then plummeted by 79.19% to -$39.9 million in 2024, then fell by 23.83% to -$49.4 million in 2025, then fell by 16.0% to -$57.3 million in 2026.
- Business Quant data shows Operating Income for SLDB at -$57.3 million in Q1 2026, -$49.4 million in Q4 2025, and -$48.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 642.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -57.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.31 Mn |
| Dec 31, 2025 | -49.40 Mn |
| Sep 30, 2025 | -48.06 Mn |
| Jun 30, 2025 | -41.69 Mn |
| Mar 31, 2025 | -40.05 Mn |
| Dec 31, 2024 | -39.90 Mn |
| Sep 30, 2024 | -35.18 Mn |
| Jun 30, 2024 | -27.79 Mn |
| Mar 31, 2024 | -26.86 Mn |
| Dec 31, 2023 | -22.27 Mn |
| Sep 30, 2023 | -23.11 Mn |
| Jun 30, 2023 | -26.84 Mn |
| Mar 31, 2023 | -32.03 Mn |
| Dec 31, 2022 | -34.57 Mn |
| Sep 30, 2022 | -21.13 Mn |
| Jun 30, 2022 | -25.38 Mn |
| Mar 31, 2022 | -25.37 Mn |
| Dec 31, 2021 | -18.65 Mn |
| Sep 30, 2021 | -18.03 Mn |
| Jun 30, 2021 | -18.69 Mn |
| Mar 31, 2021 | -16.89 Mn |
| Dec 31, 2020 | -21.35 Mn |
| Sep 30, 2020 | -21.23 Mn |
| Jun 30, 2020 | -18.97 Mn |
| Mar 31, 2020 | -26.86 Mn |
| Dec 31, 2019 | -32.33 Mn |
| Sep 30, 2019 | -29.72 Mn |
| Jun 30, 2019 | -26.97 Mn |
| Mar 31, 2019 | -30.30 Mn |
| Dec 31, 2018 | -22.39 Mn |
| Sep 30, 2018 | -19.15 Mn |
| Jun 30, 2018 | -18.18 Mn |
| Mar 31, 2018 | -15.97 Mn |
| Dec 31, 2017 | -15.16 Mn |
| Sep 30, 2017 | -13.70 Mn |
| Jun 30, 2017 | -11.89 Mn |
| Mar 31, 2017 | -14.11 Mn |